Searched for
ANTIBODY LEVELS
First AI-designed 'universal vaccine' tested in humans: UK researchersA groundbreaking vaccine, designed entirely by artificial intelligence, has been tested in humans for the first time. This experimental jab...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Ebola outbreak declared emergency of international concern: What is it, how does it spread, and is there a vaccine?The World Health Organization has declared the Ebola outbreak in Democratic Republic of Congo and Uganda a global health emergency. The vir...
- Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
- Why Some Parents in Finland Want Their Kids to Play in Dirt AgainA Finnish study transformed daycare playgrounds into biodiverse natural habitats, replacing traditional equipment with soil, plants, and fo...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- 7 surprising benefits of red bananas and how they compare with yellow varietiesRed bananas offer a unique flavor and impressive nutritional profile, boasting vitamins C and B6, potassium, and magnesium. These fruits su...
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- Covishield immune responses against Covid variants higher than Covaxin: StudyThe yet-to-be peer-reviewed study, posted on the preprint server MedRxiv on Friday, also found that when compared to pre-vaccination baseli...
- Longer interval between Covid vaccine doses generates nine times higher antibodies: StudyThe finding by researchers at the UK Health Security Agency (UKHSA) also suggests that eight months after primary infection may be an optim...
- Quality of antibodies improves for months after COVID-19 vaccination: StudyThe findings, published on Tuesday in the journal Nature, suggest that declining antibody levels in the months after vaccination primarily ...
- Covid vaccine booster provides effective antibody protection against Omicron: Lancet studyA third dose of the COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, ...
- Covid vaccinated people with prior infection may have more antibodies, says new studyFurther investigation is needed to determine whether increased post-vaccination durability in previously infected people is attributable to...
- Pfizer, AstraZeneca vaccine antibody levels may decline after 2-3 months: Lancet studyThe researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping at this rate, there are ...
- Study on antibody levels produced by vaccines flawed, says Bharat BiotechHyderabad-based Bharat Biotech said on Wednesday that a report on a recent study that compared the level of antibodies produced by Covishie...
- Pfizer jab produces less antibodies against Delta variant of coronavirus: Lancet studyThe study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that...
- Mild Covid-19 induces lasting antibody protection, study findsThe researchers from Washington University School of Medicine in St. Louis, US, noted that such cells could persist for a lifetime, churnin...
- Antibodies detectable up to 7 months after Covid infection, number depends on severity of diseaseThe study revealed that 90 per cent of subjects have detectable antibodies.
- Antibodies against coronavirus detectable up to seven months post COVID-19 onset, says studyThe study revealed that 90 per cent of subjects have detectable antibodies up to seven months post contracting COVID-19. It also found that...
Load More
